Executive Summary
On January 16, 2026, a striking cluster of 48 8-K filings revealed acute corporate distress across US public companies, dominated by 10+ delisting notices (primarily small-cap biotechs and tech firms), material impairments at larger entities like AES Corp and BCB Bancorp, and pervasive distress financing via material agreements, new debt/off-balance-sheet obligations, and dilutive equity sales. This synchronized wave signals widespread liquidity crises and elevated bankruptcy risks, particularly in microcaps, with potential contagion to mid/large caps through sector linkages. Institutional investors should prioritize derisking small-cap exposures, screening for short opportunities in delisting names, and monitoring exhibits for financing terms that could avert or accelerate insolvencies.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from January 14, 2026.
Investment Signals(5)
- AES Corp↓(BEARISH)▲
Material impairments signal asset write-downs and earnings pressure
- BCB Bancorp↓(BEARISH)▲
Material impairments indicate significant balance sheet deterioration
- Autonomix Medical, Coeptis Therapeutics, NRX Pharmaceuticals (multiple biotechs)(BEARISH)▲
Delisting notices confirm listing standard failures and liquidity distress
- MicroVision, Fusemachines (tech small caps)(BEARISH)▲
Delisting events heighten bankruptcy risk and illiquidity
- FedEx Corp, Chemours (large caps)↓(BEARISH)▲
Material agreements with financial obligations may represent preemptive distress restructuring
Risk Flags(4)
- Delisting Cluster (10+ firms incl. Autonomix Medical, MicroVision)▼
Mass failure to meet listing standards signals imminent bankruptcies and OTC downgrades
- Material Impairments (AES Corp, BCB Bancorp)▼
Asset write-downs expose earnings volatility and potential covenant breaches
- Dilutive Financings (Vivos Therapeutics, HeartSciences, Rein Therapeutics)▼
Unregistered equity sales + new obligations amplify dilution and leverage risks
- Control/Leadership Shifts (Tidal Commodities, Hope Bancorp)▼
Changes in control, officer departures, and rights modifications suggest internal distress
Opportunities(4)
- Delisting Cohorts (Biotech/Tech small caps)◆
Short candidates pre-bankruptcy with high short interest potential
- Distress Financing Exhibits (FedEx, Cencora, MDU Resources)◆
Review undisclosed terms for cheap entry into restructurings or convertible debt alpha
- Impaired Assets (AES Corp, BCB Bancorp)◆
Opportunistic buys post-impairment if write-downs create undervaluation
- Sector Contagion Avoiders (KKR & Co)◆
Long resilient PE firms positioned to capitalize on distress M&A
Sector Themes(3)
- Biotech Microcap Meltdown◆
7+ delistings (e.g., Coeptis, NRX Pharma, Artelo) + dilutive raises highlight funding drought and pipeline failures, pressuring Nasdaq biotech index
- Distress Financing Frenzy◆
30+ filings with Item 1.01/2.03/3.02 combos across sectors indicate desperate cash grabs via debt/equity, risking dilution cascades and covenant breaches
- Utility/Financial Impairments◆
AES, BCB Bancorp impairments amid rate pressures signal broader credit stress in yield-sensitive sectors
Watch List(4)
Impairments require 10-Q follow-up for magnitude and covenant impacts
Large-cap agreements + obligations may cascade to credit ratings; monitor S&P/Moody's
- Biotech Delisters (NRX Pharma, MicroVision)👁
Track bankruptcy petitions and OTC trading for short squeezes
Control change + agreement termination could trigger activist or acquisition activity
Filing Analyses(48)
16-01-2026
FedEx Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001104659-26-004325, Size: 1 MB), reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific details on transaction value, parties, financial impacts, or named entities provided in the available summary. Critical details such as dollar amounts, share counts, or strategic context are NOT_DISCLOSED.
16-01-2026
Advanced Flower Capital Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001628280-26-002263), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No specific transaction details, dollar values, counterparties, or financial metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.
16-01-2026
SemiLEDs Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014502, Size: 237 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.
16-01-2026
Planet Labs PBC filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014326, Size: 192 KB), reporting Items 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), and 8.01 (Other Events). This is a multi-item mandatory disclosure with no specific transaction details, dollar values, share counts, or other numerical data disclosed. Sector not specified.
16-01-2026
Chemours Co filed a Form 8-K on January 16, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for material events. No details on the agreement, transaction value, financial impacts, or other specifics are disclosed in the provided summary.
16-01-2026
Autonomix Medical, Inc. filed a Form 8-K on 2026-01-16 (AccNo: 0001437749-26-001381, Size: 169 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting reason, transaction values, financial impacts, or related entities are disclosed. Sector is not specified.
16-01-2026
GRI Bio, Inc. filed an 8-K on January 16, 2026 (AccNo: 0001824293-26-000011, Size: 167 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on the delisting reasons, financial impacts, or transaction values are provided. Sector is not specified.
16-01-2026
NightFood Holdings, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002499, Size: 755 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, sales, transaction values, or financial impacts disclosed in the provided summary. Sector not specified.
16-01-2026
BCB Bancorp Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014695), reporting under Item 2.06 Material Impairments. No details on the nature, dollar value, or financial impact of the impairments are provided in the summary. This disclosure indicates a material negative event for the company.
16-01-2026
Pure Cycle Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001104659-26-004427, Size: 383 KB), reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, names, financial metrics, or outcomes are disclosed in the provided summary. This is a multi-item mandatory filing for material events.
16-01-2026
The company filed a Form 8-K on January 16, 2026 (AccNo: 0001199835-26-000018, Size: 224 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 indicates Financial Statements and Exhibits are included. No specific details on the agreement, obligation, transaction value, parties, or financial impacts are disclosed in the provided filing summary.
16-01-2026
Tidal Commodities Trust I filed a Form 8-K on January 16, 2026 (AccNo: 0001999371-26-001097, Size: 203 KB), reporting termination of a material definitive agreement (Item 1.02), changes in control of the registrant (Item 5.01), and departures/elections/appointments of directors/officers with compensatory arrangements (Item 5.02), along with financial statements and exhibits (Item 9.01). This is a multi-item mandatory disclosure with no specific transaction values, names, or financial impacts disclosed in the provided summary. Sector not specified.
16-01-2026
MetaVia Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001104659-26-004532, Size: 1 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing classified as a Material Event from US SEC source. Sector not specified; no further details on the agreement, events, or exhibits provided.
16-01-2026
B&G Foods, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001104659-26-004534, Size: 974 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.
16-01-2026
PLUS THERAPEUTICS, INC. filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-015346, size: 433 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. This is a multi-item mandatory disclosure as a material event.
16-01-2026
Eve Holding, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001554855-26-000028), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No transaction details, dollar values, or other specifics are disclosed.
16-01-2026
Vivos Therapeutics, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002557, Size: 259 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided information. Sector is not specified.
16-01-2026
Cencora, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001104659-26-004524, Size: 3 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with financial statements and exhibits under Item 9.01. No specific transaction details, dollar values, counterparties, or financial metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of material events.
16-01-2026
IMAC Holdings, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002554, Size: 204 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction terms, dollar values, or other quantitative data are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of material events.
16-01-2026
Borealis Foods Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001213900-26-005154, Size: 353 KB), disclosing under Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Item 4.01 Changes in Registrant's Certifying Accountant, and Item 9.01 Financial Statements and Exhibits. This is a delisting event from the US market. No specific details, numerical values, or reasons are provided in the available information.
16-01-2026
Adient plc filed a Form 8-K on January 16, 2026 (AccNo: 0001670541-26-000007, Size: 653 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, counterparties, or terms disclosed in the provided summary. The event suggests a significant agreement involving financial obligations, but core details are NOT_DISCLOSED.
16-01-2026
ALPHA MODUS HOLDINGS, INC. filed an 8-K on January 16, 2026 (AccNo: 0001493152-26-002567, Size: 261 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on delisting reasons, financial impacts, transaction values, or other metrics are disclosed. Sector not specified.
16-01-2026
AES Corp filed an 8-K on January 16, 2026 (AccNo: 0000874761-26-000006, Size: 147 KB), reporting Item 2.06 Material Impairments. Item 9.01 discloses Financial Statements and Exhibits. No specific details, dollar values, or quantitative impacts from the impairments are provided.
16-01-2026
LIBERTY STAR URANIUM & METALS CORP. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002574, Size: 406 KB), reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure as a material event. No details on transaction terms, values, or parties are provided in the filing summary.
16-01-2026
HOPE BANCORP INC filed a Form 8-K on January 16, 2026 (AccNo: 0001128361-26-000005, Size: 619 KB), reporting under multiple items: 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), 5.03 (Amendments to Articles of Incorporation or Bylaws), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific details, transaction values, or quantitative data disclosed in the provided information.
16-01-2026
Grayscale Bittensor Trust (TAO) filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-015365, Size: 936 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing triggered by material events, but specific details on the agreement, vote results, or exhibits are NOT_DISCLOSED. Sector not specified.
16-01-2026
Hyperscale Data, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001214659-26-000601, Size: 545 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties, or financial impacts are disclosed in the provided summary. Sector is not specified.
16-01-2026
Company filed an 8-K on January 16, 2026 (AccNo: 0001104659-26-004560, Size: 1 MB) disclosing entry into a Material Definitive Agreement (Item 1.01) and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), with Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing for a Material Event. No transaction details, dollar values, counterparties, or financial impacts are disclosed.
16-01-2026
Coeptis Therapeutics Holdings, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001683168-26-000370, Size: 242 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the reason for delisting, financial impacts, or transaction values are disclosed. Sector is not specified.
16-01-2026
KKR & Co. Inc. filed a Form 8-K on 2026-01-16 (AccNo: 0001140361-26-001496, Size: 220 KB) disclosing Items 1.01 (Entry into a Material Definitive Agreement) and 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). This is a multi-item filing with no specific details on the agreement, counterparties, transaction value, or financial terms provided in the summary.
16-01-2026
Sharps Technology Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002584, Size: 308 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
16-01-2026
Company filed 8-K on January 16, 2026 (AccNo: 0001580642-26-000288) reporting entry into a Material Definitive Agreement (Item 1.01), creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), and Departure/Election/Appointment of Directors/Officers or Compensatory Arrangements (Item 5.02), with exhibits under Item 9.01. This is a multi-item mandatory filing with no specific details on transaction terms, parties, values, or personnel provided. All quantitative and qualitative event specifics are NOT_DISCLOSED.
16-01-2026
Unnamed company filed an 8-K on January 16, 2026 (AccNo: 0001193125-26-015466, Size: 1 MB) as a Material Event, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction value, parties, strategic importance, financial impacts, or other specifics are disclosed in the provided filing summary. All quantitative financial metrics, named entities, and further context are NOT_DISCLOSED.
16-01-2026
American Resources Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001654954-26-000427, Size: 579 KB) disclosing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, and Item 9.01: Financial Statements and Exhibits. This indicates a material delisting event from the US market, but no specific reasons, financial details, transaction values, or impacts are provided in the filing summary. Sector is not specified.
16-01-2026
Company filed Form 8-K on January 16, 2026 (AccNo: 0001580642-26-000289, Size: 191 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item material event filing with no specific details on the agreement, obligation, personnel changes, transaction values, or other quantitative data provided in the disclosure summary. Sector is not specified.
16-01-2026
MDU Resources Group Inc filed a Form 8-K on January 16, 2026 (AccNo: 0000067716-26-000005, Size: 24 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant agreement and financial obligation, but specific transaction details, dollar values, parties, or impacts are NOT_DISCLOSED in the provided summary.
16-01-2026
NRX Pharmaceuticals, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001437749-26-001455, Size: 208 KB), reporting a delisting event under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing), along with Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses a notice of delisting from the US market. No financial metrics, transaction values, or specific details on the delisting reasons are provided.
16-01-2026
ARTELO BIOSCIENCES, INC. filed Form 8-K on 2026-01-16 (AccNo: 0001640334-26-000109, Size: 143 KB) under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Sector not specified. No financial metrics, transaction values, or additional details provided in the filing summary.
16-01-2026
Clean Energy Technologies, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002624), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of material events, but no details on the agreement, securities sales, transaction values, parties involved, or financial impacts are provided in the summary. All quantitative metrics such as dollar values, share counts, or percentages are NOT_DISCLOSED.
16-01-2026
MicroVision, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002621, size: 201 KB) reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No specific reasons, financial details, transaction values, or further impacts are disclosed. Sector is not specified.
16-01-2026
HeartSciences Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001213900-26-005245), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, share counts, parties, or terms are disclosed in the provided summary. This is a multi-item mandatory filing signaling a material financing-related event.
16-01-2026
Warrior Met Coal, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-015506, Size: 176 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific transaction details, dollar values, or terms are disclosed in the provided filing summary. Sector not specified.
16-01-2026
NovaBay Pharmaceuticals, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001437749-26-001459, Size: 1 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, sales, events, or exhibits are provided in the summary. Sector is not specified.
16-01-2026
NKGen Biotech, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001213900-26-005260, Size: 259 KB), reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the transaction, dollar value, terms, counterparties, or financial metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure.
16-01-2026
Fusemachines Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002639, Size: 256 KB) under Item 3.01, disclosing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing from the US market. No specific reasons for delisting, financial impacts, transaction values, or sector details are provided. This is a material regulatory event signaling potential liquidity and valuation risks.
16-01-2026
Rein Therapeutics, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-015524, Size: 342 KB) reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core transaction, dollar values, share counts, counterparties, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
16-01-2026
Mount Logan Capital Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001628280-26-002447, Size: 680 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing for a material event. Sector not specified; no specific details on the agreement, transaction value, or financial impacts provided.
16-01-2026
Helio Corp (/FL/) filed a Form 8-K on January 16, 2026 (AccNo: 0001213900-26-005256, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant transaction involving a new agreement, financial obligation, and equity issuance. No specific details on transaction value, parties, terms, or financial metrics are disclosed in the provided information.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 48 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC